Panniculitis in a patient with metastatic renal cell carcinoma on a tyrosine kinase inhibitor

Nellie N. Nafissi, Nina Karlin, Mark R. Pittelkow, David J. Dicaudo, Aaron R. Mangold

Research output: Contribution to journalArticlepeer-review

1 Scopus citations


A 71-year-old female was diagnosed with localized renal cell carcinoma in July 2008 with subsequent metastasis in 2012 to the right adrenal gland, lungs, and brain. Due to disease progression, she was started on pazopanib 800 mg daily in October 2012. In November 2016, the patient developed an ill-defined, red, 10 × 15 cm indurated plaque on the left lateral upper thigh with a discrete 3 cm firm tender tumor without ulceration. An incisional biopsy was performed and showed panniculitis with features resembling sclerosing lipogranuloma. Alternative causes including rheumatologic disease and trauma were ruled out. We report the first case of pazopanib-induced panniculitis. Key clinical and histopathological features include tender subcutaneous nodules, exclusion of other causes, and fatty microcysts within a densely sclerotic background on pathology. As targeted therapies are becoming increasingly common in the field of oncology, prompt identification and reporting of adverse reactions is critical for proper management.

Original languageEnglish (US)
Pages (from-to)474-475
Number of pages2
JournalAnti-cancer drugs
Issue number4
StatePublished - Apr 1 2021


  • immunotherapy
  • panniculitis
  • pazopanib
  • rash
  • renal cell carcinoma

ASJC Scopus subject areas

  • General Medicine


Dive into the research topics of 'Panniculitis in a patient with metastatic renal cell carcinoma on a tyrosine kinase inhibitor'. Together they form a unique fingerprint.

Cite this